Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex ...

US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination ...

Jim Cramer continues to show his support for the biotech company, as evident by his most recent comments from the 14 th of ...

Vertex Pharmaceuticals VRTX announced that the European Commission (EC) has expanded the label of its blockbuster cystic ...

The new approval makes the regimen an option for around 4,000 patients in the EU who have at least one non-class I CFTR mutation.

Analysts defend the long-term profitability of health-oriented companies, traditionally defensive values that have now been ...

Stueland's journey to the genetic-testing business started as a child, when she discovered at a family reunion that multiple ...

Evercore ISI sees cheap buying opportunities in various stock market sectors as the trade war sends stocks into a bear market ...